8-K 1 b322018_8k.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 -------------- Date of Report (Date of earliest event reported): December 19, 2002 ORCHID BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 000-30267 22-3392819 ---------------- ------------ ------------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification No.) incorporation) 4390 US Route One Princeton, NJ 08540 --------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (609) 750-2200 Not Applicable ------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events. On December 20, 2002, Orchid BioSciences, Inc. announced that it had entered into a definitive agreement with Beckman Coulter, Inc. pursuant to which Beckman acquired certain assets of Orchid's SNP genotyping instruments, bioinformatic software and related consumables business. The press release regarding the acquisition attached hereto as Exhibit 99.1 is incorporated herein by reference into this Item 5. In addition, on December 27, 2002, Orchid announced that it had obtained a $10 million credit facility from Comerica, a leading financial services company. The press release regarding the credit facility attached hereto as Exhibit 99.2 is incorporated herein by reference into this Item 5. Item 7. Financial Statements and Exhibits. (c) Exhibits. 99.1 Press Release, dated December 20, 2002, announcing the acquisition of Orchid's SNP Geneotyping Instrumentation Business by Beckman Coulter, Inc. 99.2 Press Release, dated December 27, 2002, announcing Orchid's obtaining $10 million credit facility from Comerica. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORCHID BIOSCIENCES, INC. (Registrant) Date: January 6, 2003 /s/ Andrew P. Savadelis ------------------------------------ Name: Andrew P. Savadelis Title: Senior Vice President & Chief Financial Officer EXHIBIT INDEX ------------- Exhibit Number Description ------ ----------- 99.1 Press Release, dated December 20, 2002, announcing the acquisition of Orchid's SNP Genotyping Instrumentation Business by Beckman Coulter, Inc. 99.2 Press Release, dated December 27, 2002, announcing Orchid's obtaining $10 million credit facility from Comerica.